Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.49% | -26.32% | 18.57% | -9.48% | -1,528.35% |
| Total Depreciation and Amortization | -7.97% | 0.11% | 2.21% | 4.63% | 0.37% |
| Total Amortization of Deferred Charges | -2.07% | 57.80% | 7.64% | 31.03% | -10.96% |
| Total Other Non-Cash Items | -93.92% | 56.84% | -7.83% | 2.05% | 121.44% |
| Change in Net Operating Assets | -76.47% | 309.89% | -1,767.02% | 135.00% | -98.83% |
| Cash from Operations | -63.96% | 59.24% | 10.28% | -8.99% | 6.03% |
| Capital Expenditure | -100.00% | 400.00% | 99.61% | -366.36% | 85.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -100.00% | 400.00% | 99.61% | -366.36% | 68.93% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 72.60% | 87.67% | -1,398.73% | -173.83% | 113.10% |
| Issuance of Common Stock | -- | -- | -78.02% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.54% | -360.00% | 84.29% | -- | -- |
| Cash from Financing | -103.96% | 960.46% | -87.80% | 10,590.65% | 113.10% |
| Foreign Exchange rate Adjustments | 272.24% | -460.23% | 2,950.00% | 97.74% | -187.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.37% | 284.50% | -343.84% | 130.76% | 12.02% |
